Logo image of PSIG

PS INTERNATIONAL GROUP LTD (PSIG) Stock Fundamental Analysis

NASDAQ:PSIG - Nasdaq - KYG7308J1058 - Common Stock - Currency: USD

0.4353  -0.01 (-1.96%)

Fundamental Rating

2

PSIG gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 22 industry peers in the Air Freight & Logistics industry. No worries on liquidiy or solvency for PSIG as it has an excellent financial health rating, but there are worries on the profitability. PSIG has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

PSIG had negative earnings in the past year.
In the past year PSIG has reported a negative cash flow from operations.
PSIG Yearly Net Income VS EBIT VS OCF VS FCFPSIG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 2M -2M 4M -4M 6M

1.2 Ratios

PSIG has a Return On Assets (-19.58%) which is comparable to the rest of the industry.
The Return On Equity of PSIG (-45.24%) is worse than 63.64% of its industry peers.
Industry RankSector Rank
ROA -19.58%
ROE -45.24%
ROIC N/A
ROA(3y)0.89%
ROA(5y)N/A
ROE(3y)3.48%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PSIG Yearly ROA, ROE, ROICPSIG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

PSIG has a Gross Margin of 4.05%. This is in the lower half of the industry: PSIG underperforms 77.27% of its industry peers.
The Profit Margin and Operating Margin are not available for PSIG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 4.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PSIG Yearly Profit, Operating, Gross MarginsPSIG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 5 -5

More info and screens

7

2. Health

2.1 Basic Checks

PSIG does not have a ROIC to compare to the WACC, probably because it is not profitable.
PSIG has more shares outstanding than it did 1 year ago.
PSIG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PSIG Yearly Shares OutstandingPSIG Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M 25M
PSIG Yearly Total Debt VS Total AssetsPSIG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

An Altman-Z score of 3.85 indicates that PSIG is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.85, PSIG is doing good in the industry, outperforming 77.27% of the companies in the same industry.
PSIG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.85
ROIC/WACCN/A
WACC9.07%
PSIG Yearly LT Debt VS Equity VS FCFPSIG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

A Current Ratio of 1.76 indicates that PSIG should not have too much problems paying its short term obligations.
PSIG's Current ratio of 1.76 is fine compared to the rest of the industry. PSIG outperforms 68.18% of its industry peers.
A Quick Ratio of 1.76 indicates that PSIG should not have too much problems paying its short term obligations.
PSIG's Quick ratio of 1.76 is fine compared to the rest of the industry. PSIG outperforms 72.73% of its industry peers.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.76
PSIG Yearly Current Assets VS Current LiabilitesPSIG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for PSIG have decreased strongly by -214.43% in the last year.
PSIG shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -37.75%.
EPS 1Y (TTM)-214.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-214.43%
Revenue 1Y (TTM)-37.75%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-37.75%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PSIG Yearly Revenue VS EstimatesPSIG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 50M 100M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PSIG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PSIG Price Earnings VS Forward Price EarningsPSIG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PSIG Per share dataPSIG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PSIG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PS INTERNATIONAL GROUP LTD

NASDAQ:PSIG (7/11/2025, 8:00:00 PM)

0.4353

-0.01 (-1.96%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryAir Freight & Logistics
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.99%
Inst Owner Change0%
Ins Owners61.85%
Ins Owner ChangeN/A
Market Cap11.31M
AnalystsN/A
Price TargetN/A
Short Float %1.56%
Short Ratio0.27
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.13
P/FCF N/A
P/OCF N/A
P/B 1.06
P/tB 1.06
EV/EBITDA N/A
EPS(TTM)-0.22
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS3.36
BVpS0.41
TBVpS0.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -19.58%
ROE -45.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 4.05%
FCFM N/A
ROA(3y)0.89%
ROA(5y)N/A
ROE(3y)3.48%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover3.54
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.76
Quick Ratio 1.76
Altman-Z 3.85
F-Score3
WACC9.07%
ROIC/WACCN/A
Cap/Depr(3y)1.28%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.01%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-214.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-214.43%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-37.75%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-37.75%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-188.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-125.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-125.13%
OCF growth 3YN/A
OCF growth 5YN/A